Birth Control Pills, Hormone Therapy, and Lung Cancer Risk
“Ongoing hormone therapy appears to be a risk factor for worse cognitive function.” The findings add to accumulating evidence of an association between breast cancer and a decline in cognitive function, which has been the subject of research for more than a decade . The source of the problem remains open for debate and investigation. Some evidence has implicated the treatment , whereas other research has suggested the disease process itself or other factors — including treatment-induced menopause, anxiety, subclinical anemia, and high-dose chemotherapy — lead to cognitive decline, according to background information for the study. Rugo and co-investigators conducted a prospective, longitudinal study to identify factors that predict cognitive decline in patients with early breast cancer.
For the original version including any supplementary images or video, visit http://www.medpagetoday.com/MeetingCoverage/MBCS/41486
One study found that women with lung cancer who were using combination therapy HRT (both estrogen and progesterone) were more likely to die from the disease. And of course, there are other concerns with OC’s and HRT beyond lung cancer. While birth control pills may reduce that risk of lung cancer, they are associated with an increase in the risk of breast cancer . And while HRT may reduce lung cancer risk, the opposite is true for breast cancer (at least for HRT that includes both estrogen and progesterone.) There is also the risk of heart disease and blood clots.
For the original version including any supplementary images or video, visit http://lungcancer.about.com/b/2013/09/06/birth-control-pills-hormone-therapy-and-lung-cancer-risk.htm